3
Graph AI, a life sciences technology firm focused on pharmacovigilance and patient safety, has raised $3 million in a seed funding round led by Bessemer Venture Partners.
The proceeds will be used to expand its engineering team, accelerate product development, and grow its enterprise customer base globally.
Founded in 2024 by Raghav Parvataraju, Vijay Ponukumati, Mohan Konyala, and Ashutosh Bordekar, Graph AI operates in the $8 billion pharmacovigilance market, a regulatory process where pharmaceutical companies track and report adverse drug events…
